Literature DB >> 3665359

Adaptation to exercise-induced muscle damage.

P M Clarkson1, W C Byrnes, E Gillisson, E Harper.   

Abstract

1. Serum creatine kinase (CK) and muscle soreness, common indicators of muscle damage, were assessed in 16 subjects after performance of two bouts of eccentric exercise spaced 7 days apart. The purpose was (1) to examine rapid muscle adaptation when the ipsilateral limb was exercised on the second bout and (2) to investigate possible central adaptations when the contralateral limb was exercised on the second bout. 2. The LSL group (n = 7) and the LOL group (n = 9) performed the exercise with the ipsilateral and the contralateral limb, respectively. Careful attention was paid to stabilization of the subject so that the contralateral limb was not active in isometric stabilization. 3. For the LSL group, a lower CK and soreness response was found on about 2 compared with bout 1. For the LOL group, no significant difference in CK response and soreness was found between bout 1 and bout 2. 4. No repeat bout effect was found when the contralateral limb was exercised; therefore central adaptation from performance of the first exercise was minimal. Because a lower repeated bout effect was found after bout 2 using the ipsilateral limb, it was concluded that an experimental design using ipsilateral muscle groups should provide a good model to study rapid muscle adaptation to exercise damage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3665359     DOI: 10.1042/cs0730383

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  19 in total

1.  Temporal Pattern of the Repeated Bout Effect of Eccentric Exercise on Delayed-Onset Muscle Soreness.

Authors:  Michelle A Cleary; Iris F Kimura; Michael R Sitler; Zebulon V Kendrick
Journal:  J Athl Train       Date:  2002-03       Impact factor: 2.860

2.  CURRENT CONCEPTS OF PLYOMETRIC EXERCISE.

Authors:  George Davies; Bryan L Riemann; Robert Manske
Journal:  Int J Sports Phys Ther       Date:  2015-11

Review 3.  Exercise-induced muscle damage and adaptation.

Authors:  C B Ebbeling; P M Clarkson
Journal:  Sports Med       Date:  1989-04       Impact factor: 11.136

4.  Efficacy of a tart cherry juice blend in preventing the symptoms of muscle damage.

Authors:  D A J Connolly; M P McHugh; O I Padilla-Zakour; L Carlson; S P Sayers
Journal:  Br J Sports Med       Date:  2006-06-21       Impact factor: 13.800

Review 5.  Aging, functional capacity and eccentric exercise training.

Authors:  Mandy L Gault; Mark E T Willems
Journal:  Aging Dis       Date:  2013-09-25       Impact factor: 6.745

6.  Sequenced response of extracellular matrix deadhesion and fibrotic regulators after muscle damage is involved in protection against future injury in human skeletal muscle.

Authors:  Abigail L Mackey; Simon Brandstetter; Peter Schjerling; Jens Bojsen-Moller; Klaus Qvortrup; Mette M Pedersen; Simon Doessing; Michael Kjaer; S Peter Magnusson; Henning Langberg
Journal:  FASEB J       Date:  2011-03-02       Impact factor: 5.191

7.  Muscle adaptation prior to recovery following eccentric exercise.

Authors:  C B Ebbeling; P M Clarkson
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

8.  The role of exercising muscle length in the protective adaptation to a single bout of eccentric exercise.

Authors:  Malachy P McHugh; Stefan Pasiakos
Journal:  Eur J Appl Physiol       Date:  2004-12       Impact factor: 3.078

9.  Inflammatory markers CD11b, CD16, CD66b, CD68, myeloperoxidase and neutrophil elastase in eccentric exercised human skeletal muscles.

Authors:  Gøran Paulsen; Ingrid Egner; Truls Raastad; Finn Reinholt; Simen Owe; Fredrik Lauritzen; Sverre-Henning Brorson; Satu Koskinen
Journal:  Histochem Cell Biol       Date:  2012-12-07       Impact factor: 4.304

10.  Efficacy of tart cherry juice in reducing muscle pain during running: a randomized controlled trial.

Authors:  Erica T Perrier; Diane L Elliot; James C Chesnutt; Kerry S Kuehl
Journal:  J Int Soc Sports Nutr       Date:  2010-05-07       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.